Bausch Health Companies BHC
NYSE BHC
$6.84 -0.05 (-0.73%)
At close: Aug 20, 2026 · 2:01 PM UTC

Bausch Health Companies (BHC) Shares Outstanding (2009 - 2026)

Bausch Health Companies (BHC) posted Shares Outstanding (Entity) of $373.9 million for Q2 2026, little changed sequentially from $373.5 million in Q1 2026, and up 1.12% YoY from $369.7 million in Q2 2025.

Bausch Health Companies (BHC) Shares Outstanding (2009 - 2026) Analysis & Trends

Bausch Health Companies has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $373.9 million in Q2 2026.

  • Quarterly Shares Outstanding (Entity) rose 1.12% year-over-year to $373.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $373.9 million (up 1.12% YoY) and the FY2025 annual result came in at $370.5 million, up 0.73% from the prior year.
  • Shares Outstanding (Entity) held at $373.9 million in Q2 2026 per BHC's latest filing, from $373.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $373.9 million in Q2 2026 and troughed at $361.3 million in Q1 2022.
  • A 5-year average of $366.7 million and a median of $366.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) increased 0.63% in 2023, then gained 1.12% in 2026.
  • Over 5 years, Shares Outstanding (Entity) stood at $361.9 million in 2022, then gained by 0.92% to $365.2 million in 2023, then rose by 0.71% to $367.8 million in 2024, then grew by 0.73% to $370.5 million in 2025, then climbed by 0.91% to $373.9 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $373.9 million, $373.5 million, and $370.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn 1.17 Bn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn 417.60 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 1.58 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn 42.60 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 1.16 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn 101.00 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 499.50 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - 832.44 Mn
10 Bausch Health Companies 2.58 Bn 738.25 Mn 2.10 Bn 375.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 375.00 Mn
Mar 31, 2026 372.80 Mn
Dec 31, 2025 370.90 Mn
Sep 30, 2025 371.30 Mn
Jun 30, 2025 370.90 Mn
Mar 31, 2025 369.60 Mn
Dec 31, 2024 368.00 Mn
Sep 30, 2024 368.40 Mn
Jun 30, 2024 367.90 Mn
Mar 31, 2024 366.80 Mn
Dec 31, 2023 364.90 Mn
Sep 30, 2023 365.40 Mn
Jun 30, 2023 364.80 Mn
Mar 31, 2023 363.30 Mn
Dec 31, 2022 362.00 Mn
Sep 30, 2022 362.50 Mn
Jun 30, 2022 362.20 Mn
Mar 31, 2022 360.80 Mn
Dec 31, 2021 358.90 Mn
Sep 30, 2021 359.60 Mn